Łukasz Magiera
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Cancer Research top 10%
- Biomedical Engineering
- Co-authors
- Douglas T. FearonMatthew KramanJames N. ArnoldJames O. JonesEdward W. RobertsDavid A. TuvesonAarthi GopinathanMonika C. Brunner‐Weinzierl
- Topics
- Peptidase Inhibition and Analysis (3 papers)Immunotherapy and Immune Responses (2 papers)Immune Response and Inflammation (2 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United KingdomDenmarkGermany
In The Last Decade
Łukasz Magiera
8 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 922
- Immunology 610
- Molecular Biology 455
- Cancer Research 251
- Biomedical Engineering 95
Countries citing papers authored by Łukasz Magiera
This map shows the geographic impact of Łukasz Magiera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Łukasz Magiera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Łukasz Magiera more than expected).
Fields of papers citing papers by Łukasz Magiera
This network shows the impact of papers produced by Łukasz Magiera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Łukasz Magiera. The network helps show where Łukasz Magiera may publish in the future.
Co-authorship network of co-authors of Łukasz Magiera
This figure shows the co-authorship network connecting the top 25 collaborators of Łukasz Magiera. A scholar is included among the top collaborators of Łukasz Magiera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Łukasz Magiera. Łukasz Magiera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 42 | |
| 5 | 70 | |
| 6 | 95 | |
| 7 | 136 | |
| 8 | 65 | |
| 9 | Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αbreakdown → | 918 |
| 10 | 51 |
About Łukasz Magiera
Łukasz Magiera is a scholar working on Immunology, Physiology and Modeling and Simulation, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Immunotherapy and Immune Responses (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Oncology (922 citations), Immunology (610 citations) and Cancer Research (251 citations). Łukasz Magiera has collaborated with scholars based in United Kingdom, Denmark and Germany. Frequent co-authors include Douglas T. Fearon, Matthew Kraman, James N. Arnold, James O. Jones, Edward W. Roberts, David A. Tuveson, Aarthi Gopinathan, Monika C. Brunner‐Weinzierl, Maike de la Roche and Holger Lingel. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.